Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples